{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:05:11Z","timestamp":1762445111180,"version":"3.37.3"},"reference-count":5,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Pharmacol. Transl. Sci."],"published-print":{"date-parts":[[2020,10,9]]},"DOI":"10.1021\/acsptsci.0c00138","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:50:31Z","timestamp":1601056231000},"page":"1035-1036","source":"Crossref","is-referenced-by-count":1,"title":["Oh, the Frustration of Antibodies!"],"prefix":"10.1021","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3939-3756","authenticated-orcid":true,"given":"Michael S.","family":"Kinch","sequence":"first","affiliation":[{"name":"Head, Centers for Research Innovation in Biotechnology (CRIB) and Drug Discovery (CDD), Washington University in St. Louis St. Louis, Missouri 63110, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"crossref","unstructured":"Agarwal, A. (September 10, 2020) Convalescent Plasma in the Management of Moderate COVID-19 in India: An Open-Label Parallel-Arm Phase II Multicentre Randomized Controlled Trial (PLACID Trial).  MedRxiv, 20187252, version 2, DOI: 10.1101\/2020.09.03.20187252 (accessed September 16, 2020).","DOI":"10.1101\/2020.09.03.20187252"},{"key":"ref2\/cit2","unstructured":"Heidt, A. (August 24, 2020) FDA Gives Plasma Go-Ahead to Treat COVID-19, Experts Skeptical. The Scientist, https:\/\/www.the-scientist.com\/news-opinion\/fda-gives-plasma-go-ahead-to-treat-covid-19-experts-skeptical-67859 (accessed September 16, 2020)."},{"key":"ref3\/cit3","unstructured":"Dasgupta, A. (September 15, 2020) Indian Study Shows No Survival Benefit of Plasma in COVID-19.  The Scientist. https:\/\/www.the-scientist.com\/news-opinion\/indian-study-shows-no-survival-benefit-of-plasma-in-covid-19-67931 (accessed September 16, 2020)."},{"key":"ref4\/cit4","unstructured":"Eli Lilly & Co. (September 16, 2020) Lilly Announces Proof of Concept Data for Neutralizing Antibody LY-CoV555\nin the COVID-19 Outpatient Setting. https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lilly-announces-proof-concept-data-neutralizing-antibody-ly (accessed September 16, 2020)."},{"key":"ref5\/cit5","unstructured":"Nellis, R. (August 14, 2020) Convalescent Plasma Associated with Reduced COVID-19 Mortality in 35,000-Plus Hospitalized Patients.  Mayo Clinic, https:\/\/newsnetwork.mayoclinic.org\/discussion\/convalescent-plasma-associated-with-reduced-covid-19-mortality-in-35000-plus-hospitalized-patients\/ (accessed September 16, 2020)."}],"container-title":["ACS Pharmacology & Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.0c00138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:28:00Z","timestamp":1682483280000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acsptsci.0c00138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10,9]]}},"alternative-id":["10.1021\/acsptsci.0c00138"],"URL":"https:\/\/doi.org\/10.1021\/acsptsci.0c00138","relation":{},"ISSN":["2575-9108","2575-9108"],"issn-type":[{"type":"print","value":"2575-9108"},{"type":"electronic","value":"2575-9108"}],"subject":[],"published":{"date-parts":[[2020,9,25]]}}}